| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
5e-18 |
| mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-11 |
| mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |